As a substantial proportion of ALPS patients (ALPS-U) lack mutations in FAS, FASL, and CASP10; it seems likely that mutations in unknown genes encoding other downstream components of the Fas cell death pathway may give rise to the additional ALPS cases [9,10]. The gene discussed is FASLG; the disease is autoimmune lymphoproliferative syndrome.